BPC-157
One named component in the commonly understood combination. Its identity and stated amount should appear clearly in the RFQ and applicable lot documents.
Pepti · Wolverine Stack terminology guide
Peptide terminology · B2B research procurement
Wolverine Stack is an informal market name commonly used for a combination of BPC-157 and TB-500. Because it is not a standardized scientific product name, serious buyers should confirm the exact compounds, per-vial format and production-lot documents rather than relying on the nickname alone.
Direct answer
The phrase is buyer and supplier shorthand, not a fixed pharmacopoeial or scientific designation. Two listings may use the same nickname while referring to different strengths, packaging formats or whether the components are combined in one vial. The compound names and written specification are therefore more important than the nickname.
One named component in the commonly understood combination. Its identity and stated amount should appear clearly in the RFQ and applicable lot documents.
The second commonly named component. Buyers should verify that documentation addresses both components rather than presenting one unexplained purity figure.
Some buyers also use BB10 for a 5 mg + 5 mg BPC-157 and TB-500 blend. These aliases are useful for discovery, but the exact written formula controls the quotation.
Common RFQ formats
Pepti's current catalog path includes co-lyophilized BPC-157 + TB-500 blend formats such as 5 mg + 5 mg and 10 mg + 10 mg per vial. Buyers should write the complete formula instead of requesting only “Wolverine Stack.”
A quote should also state kits or vials, destination, neutral or custom labeling, and the required document scope. One kit contains 10 vials.
10 mg total peptide content per vial, with both components named separately in the requested formula.
20 mg total peptide content per vial, with both components named separately in the requested formula.
Both named components are requested in one finished vial. The finished-lot record should connect the formula and lot identity.
BPC-157 and TB-500 are supplied as separate products. This is not the same physical format as one co-lyophilized blend.
Buyer verification
| Exact formula | Write BPC-157 and TB-500 separately, including the requested amount of each component per vial. |
|---|---|
| Physical format | Confirm one co-lyophilized blend vial or two separate peptide products. |
| Lot documents | Check the applicable batch-linked COA, HPLC chromatogram and MS identity record for the quoted production lot. |
| Packaging | Confirm vial count, neutral label or private-label requirements, and whether any outer-box work is included. |
| Procurement boundary | B2B and research procurement only. Buyers confirm local regulatory compliance. |
FAQ
It is an informal market term commonly used for a BPC-157 and TB-500 peptide combination. The nickname does not define one universal strength or physical format.
That is the most common meaning in supplier and buyer conversations. The RFQ should still state both compound names and the exact amount of each component.
Either format may exist. Specify whether you need one co-lyophilized blend or separately supplied BPC-157 and TB-500 products.
Confirm the formula, production-lot reference, COA, HPLC chromatogram and MS identity record for both named components. Document availability should match the quoted lot.
Related procurement pages
Request a B2B quote
Pepti confirms the applicable procurement mode, production-lot document scope, packaging options and lead time.